Diabetic Kidney Disease and Use of SGLT2 Inhibitors

In this course, we will describe the role of the kidneys and sodium glucose transporters (SGLTs) in glucose homeostasis. We will review diagnosis, prevalence, and current treatment options for diabetes and diabetic kidney disease (DKD) and explain the mechanism of action of SGLT2 inhibitors. We will also highlight the importance of early prescribing of SGLT2 inhibitors in CKD and DKD. 

All webinars are eligible for continuing education (CE) credits. Registration is required to receive CE credits. Please click the Register button above to create an account (if necessary), and register for this session. Following the webinar, you will receive an email with a post-webinar CE survey. The survey must be completed in order to get a CE credit certificate. Fresenius Medical Care North America Renal is approved by the California Board of Registered Nursing (Provider # CEP 7570) to provide continuing education credits. Eligible participant(s) can receive credit; however, it is their responsibility to check with their licensing board to determine if they accept continuing education contact hours from the California Board of Registered Nursing.

If you would like to attend the webinar, but do not need CE credits, you do not need to pre-register. When it is time for the webinar, a general link can be accessed by clicking the down arrow (˅) next to the Register button above. This window will expand and the general link will appear under the presenter name. Copy and paste this link into your website browser to attend.